Impact Score* 2.4
Expert Opinion on Emerging Drugs provides a place for the publication of current research findings in the quickly developing fields of Pharmacology. The dominant research topics published in this academic venue are Internal medicine, Intensive care medicine, Immunology, Pharmacology and Disease.
Expert Opinion on Emerging Drugs publishes high-quality, original contributions where all submitted papers are peer reviewed to provide the best quality. The journal welcomes submissions from the research community where attention will be on the innovativeness and the practical significance of the reported research.
Expert Opinion on Emerging Drugs is covered by many abstracting/indexing services including Scopus, Journal Citation Reports ( Clarivate ) and Research.com. A number of renowned scientists considered this journal to publish their scholarly documents including Friedemann Paul, Friedemann Paul, Alain Hovnanian, Roger S. McIntyre and Paul J. Martin.
For additional information on the rules and submission requirements for authors, please see the journal website for Expert Opinion on Emerging Drugs at https://www.tandfonline.com/toc/iemd20/current .
*The metrics for this journal are compiled based on the data for scientists listed under Medicine